ISSCR Elections

Congratulations to the winners of the 2016 ISSCR elections. 

New officers will begin their terms following the ISSCR Annual Meeting in San Francisco, 22-25 June 2016. 

The current ISSCR Board of Directors consists of 24 members, and includes the president, president elect, vice president, past president, clerk and treasurer. Nominations for the board of directors were made by ISSCR members in October/November 2015. 

In the 2016 election, 4 February - 3 March, 2016, voters were invited to vote for: 

  1. Vice president
  2. Treasurer
  3. Two new members to the ISSCR Board of Directors

1. Vice President

Return to top

Douglas Melton, PhD

Douglas Melton is the Xander University Professor at Harvard and a HHMI Investigator. He is a member of Harvard’s Department of Stem Cell and Regenerative Biology and a Co-Director of Harvard's Stem Cell Institute.

Important Issues on the Horizon for ISSCR

I am honored to have been asked to stand for the position of ISSCR Vice President. The field of stem cell science has moved very quickly from discoveries on the production and characterization of stem cells to a more practical or applied focus on their use. Employing stem cells and their differentiated products for new therapeutic approaches is the unifying challenge before the ISSCR community.   While the cell types vary for each disease, there are shared challenges in making specialized cells and finding ways to transplant cells that will survive and function. The ISSCR is a special organization, one with the capacity to change the course of human health through a sound, intelligent and ethical pursuit of these challenges. 


Dr. Melton teaches several undergraduate courses and with his wife, Gail O’Keefe, serves as a Co-Master of Eliot House in Harvard College.

Dr. Melton earned a bachelor's degree in biology from the University of Illinois and then went to Cambridge University, U.K., as a Marshall Scholar. He earned a B.A. in history and philosophy of science at Cambridge and remained there for a Ph.D. in molecular biology at Trinity College and the MRC Laboratory of Molecular Biology.  Dr. Melton has served on the Scientific Advisory Boards of pharmaceutical and biotech companies and is a scientific Co-Founder of Gilead Sciences, Curis, and Semma Therapeutics.  Dr. Melton has received numerous awards for his scientific work and has twice been named to TIME magazine’s list of the year’s 100 Most Influential People. Dr. Melton is a founding member of the ISSCR Board of Directors and past Treasurer.

Research in the Melton laboratory focuses on finding a significant new treatment for Type 1 diabetes.  His laboratory analyzes the normal development of pancreas, and the autoimmune attack that leads to Type1 diabetes, in order to understand how pancreatic beta cells are made and how they become the target of autoimmunity.  The main focus of the lab is to use human stem cells to make pancreatic islet cells for transplantation into diabetics.

2. Treasurer

Return to top

Arnold Krigstein, MD, PhD

Arnold Kriegstein is the John Bowes Distinguished Professor in Stem Cell and Tissue Biology and Founding Director of the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at University of California San Francisco. 


Dr. Kriegstein received a BS from Yale University (1971), and MD and PhD from New York University (1977) with Dr. Eric Kandel as thesis advisor.  He completed Neurology Residency at the Brigham and Women’s, Children’s, and Beth Israel Hospitals, Boston, and is a board-certified clinical neurologist.  He has held academic appointments at Stanford, Yale, and Columbia before joining UCSF in 2004.  In 2001 he was named the John and Elizabeth Harris Professor of Neurology and became the founding Director of the Neural Stem Cell Program at Columbia University.  As the Founding Director of the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at UCSF, Dr. Kriegstein oversees one of the largest and most comprehensive stem cell programs in the US, encompassing over 70 laboratories focused on disorders ranging from heart disease and diabetes to cancer and diseases of the nervous system. 

Dr. Kriegstein’s research focuses on the stem cell niche and ways neural stem and progenitor cells produce neurons in the developing brain.  He was one of the first to find that radial glia (RG), long thought to simply guide neuron migration, are the primary neural stem cell population in the embryonic brain.  He also described a second type of precursor cell, an intermediate progenitor, produced by RG that contributes to the generation of neuronal diversity.  Recently he described oRG cells, a neural stem cell type in the human outer subventricular zone that accounts for the bulk of human cortical neurogenesis.  Lineage analysis links this cell type to transit amplifying daughter cells and helps explain evolutionary cortical expansion.  Currently he is analyzing gene expression profiles of single cells to link human precursor cell diversity with the generation of specific adult cortical neuron subtypes.  In addition, together with colleagues at UCSF, he has developed methods to derive human inhibitory cortical interneurons from pluripotent stem cells, a finding that may provide cell-based therapy for disorders including epilepsy and neuropathic pain.

Dr. Kriegstein serves on the editorial boards of Cell Stem Cell, Stem Cell Reports, Developmental Neuroscience, and Journal of Experimental Neurology and is currently Chair of the Publication Committee of the ISSCR.  He has been an external reviewer for RIKEN, ANR, Welcome Trust, and MRC, and reviewer and Chair of the NIH Stem Cell Study Section.  He has served as SAB member for Pfizer and advisory board member for the John Merck Scholars Program, the Allen Brain Institute, and the Stanley Center of the Broad Institute.  He is a member of the National Academy of Medicine and was twice awarded a Javits Neuroscience Investigator Award from the NINDS.  Among other honors, he was the Dodge lecturer (Washington University), the Hunt-Wilson Lecturer (American Association of Neurological Surgeons), the Lippard Lecturer (Columbia University), the Cotzius lecturer (American Academy of Neurology), and received the Solomon A. Berson Medical Alumni Achievement Award (NYU).  He was selected Senior Visiting Professor by the Chinese Academy of Sciences (2012), and Astor Visiting Professor, University of Oxford (2013).

3. New Members of the Board of Directors

Return to top

Marianne Bronner, PhD

Marianne Bronner is the Albert Billings Ruddock Professor and Executive Officer for Neurobiology, Division of Biology and Biological Engineering at the California Institute of Technology.


Marianne Bronner is a developmental biologist and Professor at Caltech, where her lab studies gene regulatory interactions underlying formation, migration and differentiation of neural crest stem cells.

Born in Budapest, Hungary, Marianne’s family escaped to Austria during the Hungarian revolution when she was a small child.  She was raised in Lawrenceville, N.J, and attended Brown University, where she received her ScB in Biophysics and then a PhD in Biophysics from Johns Hopkins University. She assumed her first faculty position at the University of California, Irvine, where she moved up the ranks from Assistant to Full Professor.  In 1996, she joined the faculty at Caltech and became the first woman to be Chair of the Faculty in 2001 to 2003. 

Bronner’s early work pioneered the use of a single cell lineage labeling approach for analyzing the developmental potential of neural crest cells in vivo to show that premigratory and migrating neural crest cells are multipotent.  Her group went on to define several of the signals underlying neural crest induction (e.g. Wnt) and segmental migration (e.g. neuropilin/Sema and Eph/ephrin).  More recently, her lab has used systems level transcriptional profiling, phylogenomic analysis and in vivo functional perturbation experiments to reveal direct connections in the gene regulatory network responsible for neural crest formation and evolutionary origin.

Dr. Bronner was President of the Society for Developmental Biology in 2009 and is currently the Editor-in-Chief of its official journal, Developmental Biology. She also serves as a monitoring editor for eLife, Journal of Cell Biology and Molecular Biology of the Cell.  She was President of the Society for Differentiation in 2014 and has served on numerous boards and committees (e.g. Gordon Research Conference, Sontag Foundation, Curci Foundation, NIDCR Board of Scientific Counselors). In 2015, she was elected to the National Academy of Sciences and in 2009 to the American Academy of Arts and Sciences.  She received the Conklin Medal from The Society for Developmental Biology in 2013, the Women in Cell Biology Senior Award from the American Society for Cell Biology in 2012, and a Javits award from the NINDS in 2002, as well as several teaching awards from her institution.

Valentina Greco, PhD

Valentina Greco is an Associate Professor in the Genetics, Cell Biology and Dermatology Departments, and a member of the Yale Stem Cell Center and Yale Cancer Center at the Medical School of Yale University (2009-present).


Dr. Greco was born in Palermo, Italy and earned her undergraduate degree in Molecular Biology at the University of Palermo, Italy. She earned her PhD with Suzanne Eaton at the EMBL/MPI-CBG, Germany (1998-2002) and her post-doc with Elaine Fuchs at the Rockefeller University (2003-2009).

The Greco Lab focuses on trying to understand how stem cells and their environment contribute to organ regeneration, and how dysregulation of growth signals leads to cancer. The Greco Lab was the first to establish the ability to visualize and manipulate stem cells and their environment in an intact mammalusing two-photon microscopy and laser ablation. By visualizing stem cells in vivo and identifying signaling pathways that regulate normal skin and skin cancer growth, her lab has made groundbreaking contributions to our understanding of organ growth and cancer regulation. Their work has provided unprecedented insights into tissue regeneration, which relies upon the coordinated activation of resident stem cells and their environment, and into key signaling pathways controlling dynamic stem cell behaviors and decisions.

Dr. Greco was the recipient of the 2014 ISSCR-BD Biosciences Outstanding Young Investigator Award and is co-chair of the ISSCR Junior Investigators Committee. She is also the recipient of the 2014 Women in Cell Biology Junior Award (WICB) for Excellence in Research from the American Society of Cell Biology (ASCB) and the 2015 Robertson Stem Cell Investigator Award from the New York Stem Cell Foundation (NYSCF).

International Society for Stem Cell Research
5215 Old Orchard Road, Suite 270
Skokie, Illinois, USA 60077
+1 224-592-5700